The DOI matches its Crossref record; 112 of the 115 references it cites were found in a registry or an index.
Research progress on the anti-hepatic fibrosis action and mechanism of natural products
Abstract
Hepatic fibrosis is the most common pathological feature of most chronic liver diseases, and its continuous deterioration gradually develops into liver cirrhosis and eventually leads to liver cancer. At present, there are many kinds of drugs used to treat liver fibrosis. However, Western drugs tend to only target single genes/proteins and induce many adverse reactions. Most of the mechanisms and active ingredients of traditional Chinese medicine (TCM) are not clear, and there is a lack of unified diagnosis and treatment standards. Natural products, which are characterized by structural diversity, low toxicity, and origination from a wide range of sources, have unique advantages and great potential in anti-liver fibrosis. This article summarizes the work done over the previous decade, on the active ingredients in natural products that are reported to have anti-hepatic fibrosis effects. The effective anti-hepatic fibrosis ingredients identified can be generally divided into flavonoids, saponins, polysaccharides and alkaloids. Mechanisms of anti-liver fibrosis include inhibition of liver inflammation, anti-lipid peroxidation injury, inhibition of the activation and proliferation of hepatic stellate cells (HSCs), modulation of the synthesis and secretion of pro-fibrosis factors, and regulation of the synthesis and degradation of the extracellular matrix (ECM). This review provides suggestions for the development of anti-hepatic fibrosis drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In advanced liver fibrosis (LF), macrophages maintain the inflammatory environment in the liver and accelerate LF deterioration by secreting proinflammatory cytokines.”
From An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis (2024) · cites this paper as [11]
In the citing paper
“Macrophages, especially bone marrow macrophages that are recruited to the liver during inflammation, act a central role in the secretion of inflammatory cytokines.[ 11 ]”
From An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis (2024) · cites this paper as [11]
Citations
Cites
1 retracted
Yu, F., Lu, Z., Chen, B., Wu, X., Dong, P., & Zheng, J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12655 · Cited by 91
RetractedAlcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
The global burden of liver disease: The major impact of China
Wang, F., Fan, J., Zhang, Z., Gao, B., & Wang, H. (2014) · Hepatology · doi:10.1002/hep.27406 · Cited by 1,262
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,239
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 773
Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression
Ramirez, T., Li, Y.-M., Yin, S., Xu, M.-J., Feng, D., Zhou, Z., Zang, M., Mukhopadhyay, P., Varga, Z. V., Pacher, P., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.004 · Cited by 186
Wang, R., Zhang, H., Wang, Y., Song, F., & Yuan, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.03.029 · Cited by 145
Pascoli, M. D., Diví, M., Rodrı́guez-Vilarrupla, A., Rosado, E., Gracia‐Sancho, J., Vilaseca, M., Bosch, J., & García‐Pagán, J. C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.012 · Cited by 136
Mathews, S., Xu, M., Wang, H., Bertola, A., & Gao, B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2014 · Cited by 127
Li, J., Li, X., Xu, W., Wang, S., Hu, Z., Zhang, Q., Deng, X., Wang, J., Zhang, J., & Guo, C. (2014) · Liver International · doi:10.1111/liv.12638 · Cited by 125
Self-citationWu, Y., Liu, X., Zhou, Q. Y., Huang, C., Meng, X., Xu, F., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.09.028 · Cited by 117
Self-citationGan, F., Liu, Q., Liu, Y., Huang, D. W., Pan, C., Song, S., & Huang, K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.047 · Cited by 113
Li, R., Xu, L., Liang, T., Li, Y., Zhang, S., & Duan, X. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.059 · Cited by 111
Effects of garlic polysaccharide on alcoholic liver fibrosis and intestinal microflora in mice
Wang, Y., Guan, M., Zhao, X., & Li, X. (2018) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1479868 · Cited by 110
Yang, F., Luo, L., Zhu, Z., Zhou, X., Wang, Y., Xue, J., Zhang, J., Cai, X., Chen, Z.-L., Ma, Q., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00929 · Cited by 107
Yan, F., Zhang, Q., Jiao, L., Han, T., Zhang, H., Qin, L., & Khalid, R. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.02.004 · Cited by 106
Liu, Y., Wen, P., Zhang, X., Dai, Y., & He, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3651 · Cited by 102
Wang, Q., Dai, X., Yang, W., Wang, H., Zhao, H., Yang, F., Yang, Y., Li, J., & Lv, X. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.012 · Cited by 95
Self-citationYu, H., Yao, Y., Bu, F., Chen, Y., Wu, Y., Yang, Y., Chen, X., Zhu, Y., Wang, Q., Pan, X., et al. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.01.004 · Cited by 92
Self-citationHotair facilitates hepatic stellate cells activation and fibrogenesis in the liver
Bian, E., Wang, Y., Yang, Y., Wu, B., Xu, T., Meng, X., Huang, C. Z., Zhang, L., Lv, X., Xiong, Z., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.009 · Cited by 91
Self-citationNaringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
Hernández‐Aquino, E., Zarco, N., Casas‐Grajales, S., Ramos‐Tovar, E., Flores‐Beltrán, R. E., Arauz, J., Shibayama, M., Favari, L., Tsutsumi, V., Segovia, J., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i24.4354 · Cited by 89
Effect of Fuzheng Huayu formula and its actions against liver fibrosis
Liu, C., Hu, Y., Xu, L., Liu, C., & Liu, P. (2009) · Chinese Medicine · doi:10.1186/1749-8546-4-12 · Cited by 82
Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis
Hsu, Y., Chiu, Y., Cheng, C., Wu, C., Lin, Y., & Huang, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04361.x · Cited by 82
Wang, X., Ikejima, K., Kon, K., Arai, K., Aoyama, T., Okumura, K., Abe, W., Sato, N., & Watanabe, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.040 · Cited by 82
Lai, L., Chen, Y., Tian, X., Li, X., Zhang, X., Lei, J., Bi, Y., Fang, B., & Song, X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.040 · Cited by 81
Chen, W., Zhang, Z., Yao, Z., Wang, L., Zhang, F., Shao, J., Chen, A., & Zheng, S. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.029 · Cited by 80
Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis
Wang, J., Li, L., Li, L., Qi, Y., Li, J., & Xu, T. (2018) · Gene · doi:10.1016/j.gene.2018.06.053 · Cited by 80
Self-citationBaltă, C., Herman, H., Boldura, O. M., Gasca, I., Roșu, M., Ardelean, A., & Hermenean, A. O. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.08.013 · Cited by 79
Choi, J. H., Jin, S. W., Choi, C. Y., Kim, H. G., Lee, G. H., Kim, Y.-A., Chung, Y., & Jeong, H. G. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b04805 · Cited by 77
Novel Insights on Notch signaling pathways in liver fibrosis
Ni, M.-M., Wang, Y.-R., Wu, W., Xia, C.-C., Zhang, Y.-H., Xu, J., Xu, T., & Li, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.051 · Cited by 73
Self-citationZhang, L., Liu, C., Meng, X., Huang, C., Xu, F., & Li, J. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2258-1 · Cited by 73
Self-citationAmeliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats
Ezhilarasan, D., Karthikeyan, S., & Vivekanandan, P. (2012) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.07.004 · Cited by 70
Shu, J.-C., He, Y.-J., Lv, X., Ye, G.-R., & Wang, L. (2009) · Journal of Natural Medicines · doi:10.1007/s11418-009-0347-3 · Cited by 67
Self-citationGuo, C., Li, J., Chen, K., Li, S., Feng, J., Liu, T., Wang, F., Zhang, R., Xu, S., Zhou, Y., et al. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s98740 · Cited by 66
Self-citationGu, Y.-J., Sun, W., Zhang, S., Li, X., & Wei, W. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2692 · Cited by 66
Potent natural products and herbal medicines for treating liver fibrosis
Chen, S., Chen, X., Lu, J., Wang, Y., & Wang, Y. (2015) · Chinese Medicine · doi:10.1186/s13020-015-0036-y · Cited by 64
Zhao, H., Zhang, Z., Chai, X., Li, G.-Q., Cui, H., Wang, H., Meng, Y.-K., Liu, H., Wang, J., Li, R., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.040 · Cited by 62
Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target
Zhan, L., Huang, C., Meng, X., Song, Y., Wu, X. Q., Yang, Y., & Li, J. (2014) · Biochimie · doi:10.1016/j.biochi.2014.10.013 · Cited by 61
Self-citationEZH2‐mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis
Yang, Y., Chen, X., Li, W., Wu, X., Huang, C., Xie, J., Zhao, Y., Meng, X., & Li, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13153 · Cited by 61
Self-citationSuppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis
Chen, X., Li, W., Chen, Y., Li, X., Li, H.-D., Huang, H., Bu, F., Pan, X., Yang, Y., Huang, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1032-9 · Cited by 61
Self-citationPeng, J., Li, X., Feng, Q., Chen, L., Xu, L., & Hu, Y. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213480741 · Cited by 60
Peng, X.-D., Dai, L., Huang, C.-Q., He, C., Yang, B., & Chen, L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.099 · Cited by 58
Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model
Sang, L., Wang, X., Xu, D.-Y., Sang, L.-X., Han, Y., & Jiang, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8334 · Cited by 55
Wang, H., Wu, G. J., Park, H. J., Jiang, P., Sit, W., van Griensven, L. J., & Wan, J. M. (2012) · Chinese Medicine · doi:10.1186/1749-8546-7-23 · Cited by 53
Zhou, D., Wang, X., Wang, Y., Xiang, X.-J., Liang, Z.-C., Zhou, Y., Xu, A., Bi, C.-H., & Zhang, L. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.05.018 · Cited by 53
miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway
Yang, J., Tao, H., Liu, L., Hu, W. M., Deng, Z.-Y., & Li, J. (2016) · Inflammation Research · doi:10.1007/s00011-016-1020-4 · Cited by 52
Self-citationEvodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway
Yang, D., Li, L., Qian, S., & Liu, L. (2017) · Journal of Natural Medicines · doi:10.1007/s11418-017-1122-5 · Cited by 51
Yuan, L., Chen, F., Lü, L., Hu, B., Chen, Z., Li, F., Zhong, M.-M., & Xia, L.-J. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.10.0016 · Cited by 51
Lin, X., Kong, L., Huang, C., Ma, T., Meng, X., He, Y., Wang, Q., & Li, J. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.009 · Cited by 51
Self-citationDNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis
Yang, J., She, Q., Yang, Y., Tao, H., & Li, J. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.07.013 · Cited by 51
Self-citationLi, J., Liu, P., Zhang, R., Cao, L., Qian, H., Liao, J., Xu, W. R., Wu, M., & Yin, Z.-F. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.030 · Cited by 50
Self-citationLack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica
Zhang, Y., Huang, D., Gao, W., Yan, J., Zhou, W., Hou, X., Liu, M., Ren, C., Wang, S., & Shen, J. (2015) · International Immunology · doi:10.1093/intimm/dxv017 · Cited by 49
Xu, T., Ni, M.-M., Xingli, Li, X., Meng, X., Huang, C., & Li, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.010 · Cited by 49
Self-citationHasan, H. F., Abdel-Rafei, M. K., & Galal, S. M. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0142 · Cited by 49
Wu, Y., Bu, F., Yu, H., Li, W., Huang, C., Meng, X., Zhang, L., Ma, T., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.002 · Cited by 49
Self-citationZhan, L., & Li, J. (2017) · Gene · doi:10.1016/j.gene.2017.10.067 · Cited by 49
Self-citationTzeng, J., Chen, M., Chung, H., & Cheng, J. (2012) · Phytotherapy Research · doi:10.1002/ptr.4829 · Cited by 47
Geng, Y., Sun, Q., Li, W., Lu, Z., Xu, H., Shi, J., & Xu, Z. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600392 · Cited by 46
Mechanism of collagen resorption in reversible hepatic fibrosis
Hutterer, F., Rubin, E., & Pópper, H. (1964) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(64)90054-1 · Cited by 43
Wan, Y., Wu, Y., Lian, L., Xie, W.-X., Li, X., Ouyang, B.-Q., Bai, T., Li, Q., Yang, N., & Nan, J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.01.002 · Cited by 43
Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis
Li, X., Wu, X., Xu, T., Li, X., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.07.003 · Cited by 43
Self-citationCheng, Y., Tian, Y., Xia, J., Wu, X., Yang, Y., Li, X., Huang, C., Meng, X., Ma, T., & Li, J. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.01.005 · Cited by 43
Self-citationWang, X., & Tian, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0584-x · Cited by 43
Jiang, Y., Wang, C., Li, Y., Wang, X., An, J.-D., Wang, Y., & Wang, X. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.028 · Cited by 41
Chen, P., Huang, C., Meng, X., & Li, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.016 · Cited by 41
Self-citationWu, F., Zheng, H., Yang, Z.-T., Cheng, B., Wu, J., Liu, X.-W., Tang, C., Lu, S., Chen, Z.-N., Song, F., et al. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.03.031 · Cited by 41
Hicks, D. F., Goossens, N., Blas‐García, A., Tsuchida, T., Wooden, B., Wallace, M. C., Nieto, N., Lade, A. G., Redhead, B., Cederbaum, A. I., et al. (2017) · Scientific Reports · doi:10.1038/srep42563 · Cited by 40
Wang, L., Yue, Z. D., Guo, M., Fang, L., Bai, L., Li, X., Tao, Y., Wang, S., Liu, Q., Zhi, D., et al. (2016) · BioMed Research International · doi:10.1155/2016/1068528 · Cited by 40
Yang, J., Lu, Y., Yang, P., Chen, Q., Wang, Y., Ding, Q., Xu, T., Li, X., Li, C., Huang, C., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27521 · Cited by 40
Self-citationWu, X., Wang, Y., Wang, S., Xu, R., & Lv, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2016.12.017 · Cited by 39
Self-citationZhang, K., Gao, Y., Zhong, M., Xu, Y., Li, J., Chen, Y., Duan, X., & Zhu, H. L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.053 · Cited by 39
Self-citationCucurbitacin‐B attenuates CC l4‐induced hepatic fibrosis in mice through inhibition of STAT ‐3
Sallam, A.-A. M., Esmat, A., & Abdel‐Naim, A. B. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13160 · Cited by 38
Wogonoside Shows Antifibrotic Effects in an Experimental Regression Model of Hepatic Fibrosis
Wang, Q., Wen, R., Lin, Q., Wang, N., Lü, P., & Zhu, X. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3751-4 · Cited by 38
Kong, R., Wang, N., Luo, H. L., & Lü, J. (2018) · Current Molecular Medicine · doi:10.2174/1566524018666180608084947 · Cited by 37
Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL
Xu, F., Zhou, D., Meng, X., Wang, X., Liu, C., Huang, C., Li, J., & Zhang, L. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.013 · Cited by 36
Self-citationWang, Y.-H., Sun, Y., Zuo, L., Wang, Y., & Huang, Y. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.10.003 · Cited by 36
Li, J., Li, ., Li, S., He, B., Mi, Y., Cao, H., Zhang, C., & Li, L. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.019 · Cited by 36
Self-citationBerberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells
Wang, N., Xu, Q., Tan, H. Y., Hong, M., Li, S., Yuen, M., & Feng, Y. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/8762345 · Cited by 36
DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis
Pan, X., Yang, Y., Meng, H., Li, H.-D., Chen, X., Huang, H., Bu, F., Yu, H., Wang, Q., Huang, C., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00553 · Cited by 36
Self-citationDong, S., Cai, F., Chen, Q., Song, Y., Sun, Y., Wei, B., Li, X., Hu, Y., Liu, P., & Su, S.-B. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.150 · Cited by 35
Wang, Y., Hong, R.-T., Xie, Y., & Xu, J.-M. (2018) · Current Medical Science · doi:10.1007/s11596-018-1871-8 · Cited by 35
Fighting Liver Fibrosis with Naturally Occurring Antioxidants
Lin, L., Zhou, F., Shen, S., & Zhang, T. (2018) · Planta Medica · doi:10.1055/a-0757-0008 · Cited by 34
Role of NLRC5 in progression and reversal of hepatic fibrosis
Liu, X., Wu, Y., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.012 · Cited by 32
Self-citationLi, W., Chen, X., Yang, Y., Huang, H., Li, H.-D., Huang, C., Meng, X., & Li, J. (2016) · Toxicology · doi:10.1016/j.tox.2016.11.004 · Cited by 32
Self-citationExosomal miRNAs as Biomarkers in the Diagnosis of Liver Disease
Wang, S., Wang, J., & Lv, X. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0011 · Cited by 32
Self-citationHuang, C., Ma, T., Meng, X., Lv, X., Zhang, L., Wang, J., & Li, J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.02.0010 · Cited by 31
Self-citationHu, Z., Qin, F., Gao, S., Zhen, Y., Huang, D., & Dong, L. (2018) · PubMed Central · Cited by 31
Yang, Y., Yang, F., Wu, X., Lv, X., & Li, J. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0437 · Cited by 30
Self-citationYu, J.-L., Li, J., Chengz, R.-G., Ma, Y., Wang, X., & Liu, J. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60062-6 · Cited by 30
Self-citationZhang, C., Liu, X., Sun, H., Meng, X., Bao, Y., Zhang, H.-P., Pan, F., & Zhang, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.005 · Cited by 28
Anti-Fibrotic Effects of Neferine on Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice
Chen, M.-S., Zhang, J.-H., Wang, J., Gao, L., Chen, X., & Xiao, J. (2015) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x15500159 · Cited by 28
Guo, Y., Liang, X., Meng, M., Chen, H., Wei, X., Li, M., Li, J., Huang, R., & Wei, J. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.07.005 · Cited by 28
Self-citationLu, C., Xu, W., Zhang, F., Shao, J., & Zheng, S. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.018 · Cited by 27
Effects of tea polyphenols on hepatic fibrosis in rats with alcoholic liver disease.
Li, Y., Zhang, X., Zhou, H., Chen, S., Zhang, Y., & Yu, C. (2004) · PubMed · Cited by 26
Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells
Ni, M.-M., Xu, T., Wang, Y.-R., He, Y.-H., Zhou, Q. Y., Huang, C., Meng, X., & Li, J. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0452-6 · Cited by 26
Self-citationPTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells
Chen, P., Cai, S.-P., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.021 · Cited by 26
Self-citationKubo, N., Saito, R., Hamano, K., Nagasawa, M., Aoki, F., Takei, I., Umezawa, K., Kuwano, H., & Kojima, I. (2013) · Liver International · doi:10.1111/liv.12328 · Cited by 25
Deng, T., Liu, J., Zhang, M., Wang, Y., Zhu, G., & Wang, J. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0474 · Cited by 24
Qiao, H., Tong, Y., Han, H., Xu, W., Ren, Z., Ouyang, J., & Chen, Y. (2011) · Die Pharmazie · doi:10.31083/ph.2011.9840 · Cited by 24
Wai, K. K., Liang, Y., Zhou, L., Cai, L., Liang, C., Liu, L., Lin, X., Huahui, W., & Lin, J. (2014) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1292 · Cited by 20
β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Pathway in Alcoholic Liver Disease
Sun, Y.-Y., Zhao, Y., Li, X., Huang, C., Meng, X., & Li, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01031 · Cited by 20
Self-citationChen, Y.-H. (2015) · The Chinese Journal of Physiology · doi:10.4077/cjp.2015.bad285 · Cited by 18
Jiang, H., Qin, X., Li, W., Ma, R., Wang, T., & Li, Z.-Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7078 · Cited by 17
TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells
Xu, D., Li, X., Li, Y., Liu, Y., Huang, C., Meng, X., & Li, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.178 · Cited by 14
Self-citationLiu, L., Jin, M., Tao, Q., Yu, L., Du, J., Wang, C., Luo, Q., Tian, X., Xu, Y., Shen, J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01572 · Cited by 12
Zhang, X., Zhang, J., Jia, L., & Xiao, S. (2016) · PubMed · Cited by 10
Lin, Y.-C., Luo, H., Wang, X., Zheng, M., Jin, Q., Chen, H., Pan, P.-L., & Zhang, J. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/3080837 · Cited by 9
Tang, X., Hu, W., Lv, Y.-C., Zhang, W., Sun, T., Jiang, Y., Zhan, X., & Zhou, S. (2018) · Medical Science Monitor · doi:10.12659/msm.909320 · Cited by 9
[Effects of Hemerocallis citrine baroni flavonids on CCl4-induced liver fibrosis of rats].
Shen, N., Huang, X.-D., Li, Z., Wang, Y., Qi, L., An, Y., & Liu, T. (2015) · PubMed · Cited by 6
Telomere, telomerase and liver disease
Aravinthan, A. D., & Alexander, G. (2017) · Liver International · doi:10.1111/liv.13630 · Cited by 5
Li, X., He, C., Wu, W., Huang, H., Li, W., & Yin, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2604 · Cited by 4
Wang, Y. L., Lv, H. Y., & Zhang, Q. (2015) · Genetics and Molecular Research · doi:10.4238/2015.september.21.9 · Cited by 3
Cited by
Sorted by citations
Wu, H., Chen, G., Wang, J., Deng, M., Yuan, F., & Gong, J. (2019) · Cell Proliferation · doi:10.1111/cpr.12731 · Cited by 90
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Wang, F.-D., Zhou, J., & Chen, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 79
Zhang, Q., Luo, P., Zheng, L., Chen, J., Zhang, J., Tang, H., Liu, D., He, X., Shi, Q., Gu, L., et al. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.06.001 · Cited by 56
Self-citationZhou, L., Liang, Q., Li, Y., Cao, Y., Li, J., Yang, J., Liu, J., Bi, J., & Liu, Y. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.065 · Cited by 51
Self-citationWang, H., Ma, J.-X., Zhou, M., Si, J., & Cui, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.965934 · Cited by 49
Metadata
- Authors
- Shan, L., Liu, Z., Ci, L., Shuai, C., Lv, X., & Li, J.
- Affiliations
- Anhui Medical University (CN)
- Corresponding author
- Lv, Xiongwen
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 75
- Pages
- 105765
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2963885368
- Cited by
- 111
- References
- 115
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 21 · 2023: 25 · 2022: 25 · 2021: 7 · 2020: 6 · 2019: 1
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81270498)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Analysis
- Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
- Keywords
- liver fibrosis, traditional Chinese medicine, flavonoids, saponins, polysaccharides, alkaloids, liver inflammation, lipid peroxidation, hepatic stellate cells, extracellular matrix, liver cirrhosis, drug development
- MeSH terms
- Animals, Biological Products, Humans, Liver Cirrhosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review